1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Nerve Repair and Regeneration Market by Application, & by Products - Global Forecast to 2020

The global nerve repair and regeneration market is expected to reach USD 10,398.79 million by 2020 from USD 5,945.69 million in 2015 at a CAGR of 11.83%. Nerve injuries are most common in the upper (hand and arm) and lower (leg) extremities. Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, such as direct cuts from a knife. Injury to a nerve can stop signals to and from the brain. Surgical nerve repair involves the exploration of the injured nerve and the removal of injured tissue from the nerve endings. Nerve repair and regeneration product are used through surgical interventions to restore normal function in nerves.

The rapidly increasing incidence of peripheral nerve injuries and neurological disorders is a major growth driver for this market. Furthermore, technological advancement in nerve repair and favorable reimbursement policies will aid the growth of this market.

This report segments the global nerve repair and regeneration market by product, application, and geography. The application segments included in this report are direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and neurostimulation and neuromodulation surgery. The direct nerve repair/neurorrhaphy segment is further categorized into epineural repair, perineural repair, and group fascicular repair. The nerve grafting surgeries segment is further categorized into autografts, allografts, and xenografts. The neurostimulation and neuromodulation segment is further categorized into external and internal neurostimulation and neuromodulation surgeries.

The product segments included in this report are biomaterials and neurostimulation and neuromodulation devices. The subsegments of the biomaterials segment are nerve conduits, nerve protectors, nerve wraps, and nerve connectors. The neurostimulation and neuromodulation devices segment is further categorized into internal and external neurostimulation and neuromodulation devices. The subsegments of the internal neurostimulation and neuromodulation product segment are spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation. The subsegments of the external neurostimulation and neuromodulation products segment are transcutaneous electrical nerve stimulation and transcranial magnetic stimulation.

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America is expected to account for the largest share of the global nerve repair and regeneration market in 2015. A number of factors, such as the high prevalence of chronic disorders like epilepsy, Parkinson’s, Alzheimer’s, chronic pain, urine and fecal incontinence, and depression, along with rise in aging population, will drive the neuromodulation market in North America. Furthermore, according to the Centers for Disease Control and Prevention, about 80% of people aged 65 and above suffer from at least one chronic condition. All these factors are expected to provide an impetus to the growth of the North American nerve repair and regeneration market. However, the high cost of neuromodulation devices and the presence of alternate therapies will restrain market growth.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global nerve repair and regeneration market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their nerve repair and regeneration market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all subsegments. It maps the market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the nerve repair and regeneration market that covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and make strategic growth decisions.

The report provides insights on the following:
- Product Development/Innovation: Product portfolios of the top players in the nerve repair and regeneration market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the nerve repair and regeneration market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various nerve repair and regeneration products across geographies
- Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the nerve repair and regeneration market

Table Of Contents

Nerve Repair and Regeneration Market by Application, and by Products - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.3 MARKET SHARE ESTIMATION 22
2.3.1 KEY DATA FROM SECONDARY SOURCES 22
2.3.2 KEY DATA FROM PRIMARY SOURCES 22
2.3.3 ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 29
4.1 GLOBAL NERVE REPAIR AND REGENERATION MARKET OVERVIEW 29
4.2 LIFE CYCLE ANALYSIS, BY REGION 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET SEGMENTATION 33
5.2.1 BY PRODUCT 33
5.2.2 BY APPLICATION 34
5.3 MARKET DYNAMICS 34
5.3.1 DRIVERS 36
5.3.1.1 Large numbers of nerve injuries and increasing incidences of neurological disorders 36
5.3.1.2 Rapidly aging population worldwide 36
5.3.1.3 Technological advancements in nerve repair to aid market growth 37
5.3.1.4 Favorable reimbursement policies 37
5.3.1.5 Expanded target applications and new indications are expected to increase the demand for neuromodulation devices. 38
5.3.2 RESTRAINTS 39
5.3.2.1 Lack of patient awareness 39
5.3.2.2 Dearth of professionals, including trained surgeons 39
5.3.3 OPPORTUNITIES 39
5.3.3.1 Novel therapies such as stem cell therapy 39
5.3.3.2 Emerging markets 40
5.3.4 CHALLENGES 41
5.3.4.1 Donor site morbidity 41
5.3.4.2 Inadequate nerve regeneration by conduits 41
5.3.4.3 Stringent regulatory frameworks and time-consuming approval processes 41
6 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT 43
6.1 INTRODUCTION 44
6.2 NEUROSTIMULATION AND NEUROMODULATION DEVICES 46
6.2.1 INTERNAL NEUROSTIMULATION DEVICES 48
6.2.1.1 Spinal cord stimulation 49
6.2.1.2 Deep brain stimulation 50
6.2.1.3 Vagus nerve stimulation 51
6.2.1.4 Sacral nerve stimulation 52
6.2.1.5 Gastric electrical stimulation 53
6.2.2 EXTERNAL NEUROSTIMULATION DEVICES 54
6.2.2.1 Transcutaneous electrical nerve stimulation 55
6.2.2.2 Transcranial magnetic stimulation 56
6.3 BIOMATERIALS 57
6.3.1 NERVE CONDUITS 58
6.3.2 NERVE PROTECTORS 59
6.3.3 NERVE WRAPS 60
6.3.4 NERVE CONNECTORS 60
7 NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION 61
7.1 INTRODUCTION 62
7.2 NEUROSTIMULATION AND NEUROMODULATION SURGERIES 64
7.2.1 INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES 66
7.2.2 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES 66
7.3 DIRECT NERVE REPAIR/NEURORRHAPHY 67
7.3.1 EPINEURAL REPAIR 69
7.3.2 PERINEURAL REPAIR 69
7.3.3 GROUP FASCICULAR REPAIR 70
7.4 NERVE GRAFTING 71
7.4.1 AUTOGRAFT 72
7.4.2 ALLOGRAFT 73
7.4.3 XENOGRAFT 74
7.5 STEM CELL THERAPY 75
8 NERVE REPAIR AND REGENERATION MARKET, BY REGION 76
8.1 INTRODUCTION 77
8.2 NORTH AMERICA 79
8.3 EUROPE 86
8.4 ASIA 91
8.5 REST OF THE WORLD 98
9 COMPETITIVE LANDSCAPE 103
9.1 INTRODUCTION 103
9.2 STRATEGIC OVERVIEW 103
9.3 LEADING PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET 105
9.4 COMPETITIVE SITUATION AND TRENDS 107
9.4.1 NEW PRODUCT LAUNCHES 107
9.4.2 ACQUISITIONS AND MERGERS 108
9.4.3 EXPANSION 109
9.4.4 AGREEMENTS 110
10 COMPANY PROFILES 111
(Overview, Financials, Products and Services, Strategy, and Developments)*
10.1 INTRODUCTION 111
10.2 AXOGEN, INC. 112
10.3 BAXTER INTERNATIONAL INC. 114
10.4 BOSTON SCIENTIFIC CORPORATION 116
10.5 CYBERONICS, INC. 119
10.6 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 122
10.7 MEDTRONIC, PLC. 125
10.8 ST. JUDE MEDICAL, INC. 129
10.9 STRYKER CORPORATION 132
10.10 ORTHOMED S.A.S. 134
10.11 POLYGANICS B.V. 135

*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
11 APPENDIX 136
11.1 INSIGHTS OF INDUSTRY EXPERTS 136
11.2 DISCUSSION GUIDE 137
11.3 OTHER DEVELOPMENTS (JANUARY 2012-JUNE 2015) 139
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 141
11.5 AVAILABLE CUSTOMIZATIONS 142
11.6 RELATED REPORTS 143


LIST OF TABLES

TABLE 1 NERVE REPAIR AND REGENERATION MARKET SUMMARY 24
TABLE 2 INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES AND NEUROLOGICAL DISORDERS ARE PROPELLING THE GROWTH OF THE NERVE REPAIR AND REGENERATION MARKET 38
TABLE 3 LACK OF TRAINED PROFESSIONALS TO NEGATIVELY IMPACT THE GROWTH OF THE NERVE REPAIR AND REGENERATION MARKET 39
TABLE 4 INCREASING USE OF STEM CELL THERAPY IS PAVING NEW GROWTH AVENUES FOR PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET 41
TABLE 5 STRINGENT REGULATORY FRAMEWORKS ARE A MAJOR CHALLENGE FOR PLAYERS IN THE NERVE REPAIR AND REGENERATION MARKET 42
TABLE 6 NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 45
TABLE 7 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 46
TABLE 8 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 47
TABLE 9 INTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 48
TABLE 10 INTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 48
TABLE 11 SPINAL CORD STIMULATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 49
TABLE 12 DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 50
TABLE 13 VAGUS NERVE STIMULATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 51
TABLE 14 SACRAL NERVE STIMULATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 52
TABLE 15 GASTRIC ELECTRICAL STIMULATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 53
TABLE 16 EXTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 54
TABLE 17 EXTERNAL NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 54
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 55
TABLE 19 TRANSCRANIAL MAGNETIC STIMULATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 56
TABLE 20 BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 57
TABLE 21 BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 58
TABLE 22 NERVE CONDUITS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 59
TABLE 23 NERVE PROTECTOR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 59
TABLE 24 NERVE WRAPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 60
TABLE 25 NERVE CONNECTOR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 60
TABLE 26 NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 63
TABLE 27 NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 64
TABLE 28 NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 65
TABLE 29 INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 66
TABLE 30 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 66
TABLE 31 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 67
TABLE 32 DIRECT NERVE REPAIR/NEURORRHAPHY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 68
TABLE 33 EPINEURAL REPAIR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 69
TABLE 34 PERINEURAL REPAIR MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 69
TABLE 35 GROUP FASCICULAR REPAIR MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 70
TABLE 36 NERVE GRAFTING MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 71
TABLE 37 NERVE GRAFTING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 72
TABLE 38 AUTOGRAFT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 73
TABLE 39 ALLOGRAFT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 73
TABLE 40 XENOGRAFT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 74
TABLE 41 STEM CELL THERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 75
TABLE 42 NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 78
TABLE 43 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 81
TABLE 44 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 82
TABLE 45 NORTH AMERICA: INTERNAL NEUROSTIMULATION MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 83
TABLE 46 NORTH AMERICA: EXTERNAL NEUROMODULATION MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 83
TABLE 47 NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 84
TABLE 48 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 85
TABLE 49 EUROPE: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 87
TABLE 50 EUROPE: NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 87
TABLE 51 EUROPE: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 88
TABLE 52 EUROPE: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 88
TABLE 53 EUROPE: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 89
TABLE 54 EUROPE: NERVE REPAIR AND REGENERATION MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 90
TABLE 55 ASIA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 93
TABLE 56 ASIA: NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 94
TABLE 57 ASIA: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 94
TABLE 58 ASIA: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 95
TABLE 59 ASIA: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 96
TABLE 60 ASIA: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 97
TABLE 61 ROW: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 99
TABLE 62 ROW: NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 99
TABLE 63 ROW: INTERNAL NEUROSTIMULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 100
TABLE 64 ROW: EXTERNAL NEUROMODULATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 100
TABLE 65 ROW: BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 101
TABLE 66 ROW: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 102
TABLE 67 MARKET DEVELOPMENTS BETWEEN 2012 AND 2015 107
TABLE 68 NEW PRODUCT LAUNCHES, 2012-2015 107
TABLE 69 ACQUISITIONS AND MERGERS, 2012-2015 108
TABLE 70 EXPANSIONS, 2012-2015 109
TABLE 71 AGREEMENTS, 2012-2015 110


LIST OF FIGURES

FIGURE 1 GLOBAL NERVE REPAIR AND REGENERATION MARKET 15
FIGURE 2 RESEARCH DESIGN 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 19
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 20
FIGURE 6 DATA TRIANGULATION METHODOLOGY 21
FIGURE 7 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015 VS. 2020 25
FIGURE 8 BIOMATERIALS MARKET, BY PRODUCT, 2015 VS. 2020 25
FIGURE 9 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY PRODUCT, 2015 VS. 2020 26
FIGURE 10 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY PRODUCT, 2015 VS. 2020 26
FIGURE 11 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET,
BY PRODUCT, 2015 VS. 2020 27
FIGURE 12 NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2015 VS. 2020 27
FIGURE 13 INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES and NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH 29
FIGURE 14 NEUROSTIMULATION and NEUROMODULATION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 30
FIGURE 15 ASIA TO WITNESS FASTEST GROWTH RATE IN THE FORECAST PERIOD
(2015 TO 2020) 30
FIGURE 16 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES 31
FIGURE 17 NERVE REPAIR AND REGENERATION MARKET SEGMENTATION: BY PRODUCT 33
FIGURE 18 NERVE REPAIR AND REGENERATION MARKET SEGMENTATION: BY APPLICATION 34
FIGURE 19 INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES AND NEUROLOGICAL DISORDERS WILL DRIVE THE NERVE REPAIR AND REGENERATION MARKET IN THE FORECAST PERIOD 35
FIGURE 20 GROWING AGING POPULATION IS AN IMPORTANT DRIVER FOR THE NERVE REPAIR AND REGENERATION MARKET 37
FIGURE 21 GROWTH IN HEALTHCARE EXPENDITURE IN ASIA AND ROW OUTPACING THAT OF NORTH AMERICA AND EUROPE 40
FIGURE 22 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT 44
FIGURE 23 NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT,
2015 (USD MILLION) 45
FIGURE 24 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE MARKET IN 2015 46
FIGURE 25 NORTH AMERICA EXPECTED TO HOLD LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES SEGMENT 47
FIGURE 26 NERVE CONDUITS ACCOUNT FOR THE LARGEST SHARE OF THE BIOMATERIALS SEGMENT IN 2015 57
FIGURE 27 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE BIOMATERIALS MARKET DURING THE FORECAST PERIOD 58
FIGURE 28 NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION 62
FIGURE 29 NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION,
2015 (USD MILLION) 63
FIGURE 30 INTERNAL SURGERIES ACCOUNT FOR THE LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION APPLICATION SEGMENT 64
FIGURE 31 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE NEUROSTIMULATION AND NEUROMODULATION SURGERIES SEGMENT IN 2015 65
FIGURE 32 EPINEURAL REPAIR ACCOUNTS FOR THE LARGEST SHARE OF THE DIRECT NERVE REPAIR/NEURORRHAPHY SEGMENT IN 2015 67
FIGURE 33 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE DIRECT NERVE REPAIR/NEURORRHAPHY SEGMENT IN 2015 68
FIGURE 34 AUTOGRAFTS ACCOUNT FOR THE LARGEST SHARE OF THE NERVE GRAFTING SEGMENT IN 2015 71
FIGURE 35 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE NERVE GRAFTING SEGMENT IN 2015 72
FIGURE 36 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE STEM CELL THERAPY SEGMENT IN 2015 75
FIGURE 37 NERVE REPAIR AND REGENERATION MARKET SEGMENTATION, BY REGION 77
FIGURE 38 NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION
(MARKET SIZE AND GROWTH RATE) 77
FIGURE 39 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT 80
FIGURE 40 NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET IN NORTH AMERICA 81
FIGURE 41 INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE MARKET IN NORTH AMERICA IN 2015 82
FIGURE 42 NERVE CONDUITS TO FORM THE LARGEST SEGMENT OF THE BIOMATERIALS MARKET IN NORTH AMERICA 84
FIGURE 43 NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN NORTH AMERICA (2015) 85
FIGURE 44 NEUROSTIMULATION AND NEUROMODULATION DEVICES DOMINATED THE MARKET IN EUROPE (2015) 86
FIGURE 45 INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN EUROPE (2015) 87
FIGURE 46 NERVE CONDUITS TO FORM THE LARGEST SEGMENT OF THE BIOMATERIALS MARKET IN EUROPE (2015) 89
FIGURE 47 NEUROSTIMULATION AND NEUROMODULATION SURGERY ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN EUROPE 90
FIGURE 48 ASIA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT 92
FIGURE 49 NEUROSTIMULATION AND NEUROMODULATION DEVICES TO DOMINATE THE MARKET IN ASIA (2015) 93
FIGURE 50 INTERNAL NEUROSTIMULATION TO FORM THE LARGEST SEGMENT OF THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN ASIA 94
FIGURE 51 NERVE CONDUITS TO COMMAND THE LARGEST SHARE OF THE BIOMATERIALS MARKET IN ASIA 95
FIGURE 52 NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE MARKET IN ASIA (2015) 96
FIGURE 53 NEUROSTIMULATION AND NEUROMODULATION DEVICES DOMINATED THE ROW MARKET IN 2015 98
FIGURE 54 INTERNAL NEUROSTIMULATION TO DOMINATE THE NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET IN THE ROW 99
FIGURE 55 NERVE CONDUITS ESTIMATED TO COMMAND THE LARGEST SHARE OF THE BIOMATERIALS MARKET IN THE ROW 101
FIGURE 56 NEUROSTIMULATION AND NEUROMODULATION SURGERY TO BE THE LARGEST APPLICATION SEGMENT OF THE ROW MARKET (2015) 102
FIGURE 57 KEY DEVELOPMENTS IN THE NERVE REPAIR AND REGENERATION MARKET,
2012-2015 104
FIGURE 58 NERVE REPAIR AND REGENERATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 105
FIGURE 59 SNAPSHOT OF FINANCIAL PERFORMANCE OF LEADING MARKET PLAYERS 111
FIGURE 60 AXOGEN, INC.: COMPANY SNAPSHOT 112
FIGURE 61 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT 114
FIGURE 62 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 116
FIGURE 63 CYBERONICS, INC.: COMPANY SNAPSHOT 119
FIGURE 64 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT 122
FIGURE 65 MEDTRONIC, PLC.: COMPANY SNAPSHOT 125
FIGURE 66 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT 129
FIGURE 67 STRYKER CORPORATION: COMPANY SNAPSHOT 132

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million ...

Laparoscopic Instruments Market by Product, Application, End User - Analysis & Global Forecast to 2021

Laparoscopic Instruments Market by Product, Application, End User - Analysis & Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global laparoscopic instruments market is expected to reach USD 11.68 billion by 2021 from USD 7.61 billion in 2016, growing at a CAGR of 8.9%. Over the years, factors such as growing patient and physician ...

Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022

Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Cardiovascular Surgery Devices Market Outlook to 2022, provides key market data on ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.